TBPH
Theravance Biopharma, Inc.
NASDAQ · KYHealthcareBiotechnology
$16.81-0.71%
Price as of Jul 20, 2026
TBPH valuation
Theravance Biopharma, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 12.40x
- P/E 2026E
- 18.74x
- P/E 2027E
- —
- P/E 2028E
- 47.95x
- P/S forward
- 12.24x
Trailing multiples
- P/E TTM
- 7.43x
- PEG TTM
- —
- Price / book
- 2.98x
- Price / sales
- 7.89x
- Price / cash flow
- 3.22x
Enterprise value
- Enterprise value
- $545.2M
- EV / sales
- 4.97x
- EV / EBITDA
- 3.83x
- EV / EBIT
- 6195.90x
- Market cap
- $866.6M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.